The Ultrasound Devices Market, estimated at USD 8.74 Bn in 2025, is expected to exhibit a CAGR of 5.6% and reach USD 12.81 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on research and development activities, in order to receive product approvals from the regulatory authorities, and this is expected to drive the global ultrasound devices market growth. For instance, in October 2025, GE Healthcare, a medical technology company, announced that it had received U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which has been updated with artificial intelligence (AI)-based capabilities that let doctors do more accurate and timely tests.
Global Ultrasound Devices Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems regarding the transportation of things from one place to another.
However, the COVID-19 had positive impact on the global ultrasound devices market. For instance, in November 2025, GE Healthcare expanded AI, digital, and imaging solutions and launched a slate of new intelligently efficient solutions that include the LOGIQ E10 Series, ultrasound systems that harness artificial intelligence (AI) technology to drive workflow productivity during the COVID-19 crisis.
Global Ultrasound Devices Market: Key Developments
On July 27, 2023, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it had been granted FDA clearance for its AI-powered ultrasound guidance technology. The UltraSight real-time AI guidance software can assist medical professionals without sonography experience in acquiring cardiac ultrasound images at the point of care in multiple settings, allowing for more widespread detection of heart disease and providing patients easier access to cardiac monitoring.